Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Induction Chemotherapy and Chemoradiation in mNPC
NCT02633176Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2015
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
KL-140
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02633176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633176.